McDiarmid et al developed the Pediatric End-Stage Liver Disease (PELD) model to help evaluate children with end-stage liver disease. This can help identify patients for liver transplantation.
Parameters:
(1) age
(2) serum albumin in g/dL
(3) serum total bilirubin in mg/dL
(4) International Normalized Ratio (INR)
(5) height (and growth failure)
Parameter |
Finding |
Points |
age in years |
< 1 year of age |
1 |
|
>= 1 year of age |
0 |
growth failure |
height > 2 standard deviations below mean for age (Z score < -2) |
1 |
|
height <= 2 standard deviations below mean for age |
0 |
PELD score =
= 10 * ((0.463 * (points for age)) + (0.667 * (points for growth failure)) - (0.687 * LN(albumin)) + (0.480 * LN(total bilirubin)) + (1.857 * LN(INR)))
where:
• LN = natural logarithm, base e
Purpose: To evaluate the Pediatric End-Stage Liver Disease (PELD) score for a pediatric patient with advanced liver disease.
Specialty: Gastroenterology
Objective: other testing, severity, prognosis, stage, selection
ICD-10: Z94.4, K72.1,